Brazilian stocks posted strong gains in the first quarter of 2026, with the Global X Brazil Active ETF up 18.07% and the MSCI Brazil Index rising over 19%. This growth was driven by higher commodity prices, resilient domestic demand, improving fiscal outlook, and favorable sector performance in energy and financials. Investors were attracted by low valuation multiples, commodity exposure, easing monetary policy, and an active political calendar, suggesting continued interest in the market.
A class action lawsuit has been filed against Nano-X Imaging Ltd. and some of its officers, accusing them of making false and misleading statements about the company's operations and prospects between March 31, 2025, and April 17, 2026. The lawsuit c...
The osteoarthritis market is projected to grow at a moderate CAGR of 3% from 2026 to 2036, driven by an aging population and increasing disease prevalence. Emerging therapies like LEVI-04, ZILOSUL, TissueGene-C, and others are expected to enter the m...
Rhythm Pharmaceuticals reported encouraging six-month Phase 2 trial results for setmelanotide in patients with Prader-Willi syndrome, showing improvements in BMI, body composition, hyperphagia, and behavior. The study involved 18 patients aged 6 to 2...
AstraZeneca received FDA approval for Truqap (capivasertib) combined with abiraterone and prednisone to treat PTEN-deficient metastatic prostate cancer, marking the first targeted therapy for this group. The approval was based on Phase III trial data...
TripAdvisor has agreed to sell its European restaurant reservation platform, TheFork, to American Express for $700 million in cash. TheFork generated $232 million in revenue and $28 million in adjusted EBITDA in the past year. This sale supports Trip...
